Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Anemia
22%
Boceprevir
23%
CC Genotype
19%
Chronic Hepatitis B
78%
Chronic Hepatitis C
46%
Clinical Outcomes
23%
COVID-19
67%
Daclatasvir
29%
Direct-acting Antivirals
24%
Entecavir
48%
Gene Polymorphism
21%
Genotype
32%
Genotype 1
19%
Genotype E
37%
GS-331007
21%
Hepatitis B e Antigen (HBeAg)
39%
Hepatitis B Surface Antigen (HBsAg)
23%
Hepatitis C Virus
42%
Hepatitis C Virus Genotypes
18%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
23%
HIV-infected Patients
19%
Hospitalized Patients
41%
IL28B
36%
Interferon-free Therapy
20%
Interferon-α (IFN-α)
21%
Italy
34%
Mixed Cryoglobulinemia
27%
MS Method
34%
Multivariate Analysis
21%
Nave
41%
Pathway Genes
24%
Peginterferon
21%
Pegylated Interferon
57%
Peripheral Blood Mononuclear Cells
36%
Pharmacogenetics
43%
Plasma Concentration
59%
Polymorphism
22%
Retrospective Analysis
36%
Ribavirin
100%
Rs12979860
26%
Rs8099917
28%
SARS-CoV-2 Infection
22%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
18%
Sofosbuvir
40%
Sustained Virological Response
33%
Telaprevir
38%
Tenofovir
21%
Triple Therapy
22%
Virological Response
35%
Vitamin D Pathway
33%
Immunology and Microbiology
Alpha2a Interferon
9%
Antigen
5%
Blood Level
14%
Blood Plasma
15%
Cardiovascular System
6%
Cohort Effect
6%
Coinfection
9%
Comorbidity
11%
COVID-19
64%
Cryoglobulinemia
27%
DNA Polymorphism
12%
DNA Virus
13%
Epidemiology
6%
HBsAg
42%
HBV DNA
7%
Hepatitis
11%
Hepatitis B
94%
Hepatitis B Antigen
42%
Hepatitis B Virus
59%
Hepatitis B(e) Antigen
37%
Hepatitis C
36%
Hepatitis C Virus
36%
Hepatitis C Virus Genotype 1
11%
Hepatitis D
6%
Hospital Mortality
21%
Human Immunodeficiency Virus
7%
Infection
71%
Infectious Disease
71%
interferon
40%
Interleukin 28B
13%
Kidney Concentrating Capacity
7%
Liver Function
6%
Mortality Rate
9%
Peginterferon Alpha
14%
Pegylated Interferon
63%
Peripheral Blood Mononuclear Cell
7%
Pharmacogenetic Testing
6%
Pharmacogenetics
13%
Poly(ethylene Glycol)
18%
Polyethylene Glycol
18%
Postcovid Syndrome
11%
Prevalence
14%
Ribavirin
49%
Ribonucleic Acid
6%
Seroconversion
7%
Severe Acute Respiratory Syndrome
8%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Single Nucleotide Polymorphism
18%
Tenofovir
26%
Viral Load
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
11%
Adverse Event
12%
Albumin
7%
Anemia
11%
Antivirus Agent
20%
Boceprevir
23%
Chronic Hepatitis B
20%
Chronic Hepatitis C
28%
Comorbidity
9%
Coronavirinae
17%
Cryoglobulinemia
11%
Daclatasvir
29%
Dasabuvir
16%
Diseases
27%
Entecavir
16%
Hemolytic Anemia
6%
Hepatitis B
7%
Hepatitis B Virus
35%
Hepatitis C
12%
Hepatitis C Virus
14%
Hepatitis C Virus Genotype 1
15%
Hepatitis C Virus Genotype 4
8%
Hepatocyte Nuclear Factor 4
8%
Hospital Mortality
10%
Infection
32%
Interferon
13%
Liver Cell Carcinoma
9%
Liver Cirrhosis
14%
Liver Fibrosis
7%
Methadone
8%
Ombitasvir
16%
Paritaprevir
16%
Peginterferon
29%
Pharmacogenetics
37%
Pharmacokinetics
27%
Pneumonia
9%
Prospective Study
12%
Proteinase Inhibitor
16%
Remdesivir
11%
Ribavirin
79%
Ritonavir
16%
SARS Coronavirus
6%
Simeprevir
11%
Sofosbuvir
26%
Telaprevir
38%
Telbivudine
11%
Tenofovir
11%
Therapeutic Drug Monitoring
6%
Ultra High Performance Liquid Chromatography
12%
Vitamin D
22%
